JD Health International Inc. (HKG:6618)
Hong Kong
· Delayed Price · Currency is HKD 43.00
-0.30 (-0.69%)
Jun 30, 2025, 4:08 PM HKT
JD Health International Market Cap
JD Health International has a market cap or net worth of 137.60 billion as of June 30, 2025. Its market cap has increased by 63.11% in one year.
Market Cap
137.60B
Enterprise Value
83.37B
Revenue
61.89B
Ranking
n/a
PE Ratio
30.61
Stock Price
43.00
Market Cap Chart
Since December 8, 2020, JD Health International's market cap has decreased from 343.98B to 137.60B, a decrease of -60.00%. That is a compound annual growth rate of -18.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 137.60B | 53.10% |
| Dec 31, 2024 | 89.88B | -27.91% |
| Dec 29, 2023 | 124.67B | -45.05% |
| Dec 30, 2022 | 226.89B | 15.58% |
| Dec 31, 2021 | 196.31B | -58.90% |
| Dec 31, 2020 | 477.66B | 38.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 252.86B |
| Hansoh Pharmaceutical Group Company | 167.38B |
| Innovent Biologics | 129.81B |
| WuXi Biologics | 101.11B |
| Sino Biopharmaceutical | 88.71B |
| CSPC Pharmaceutical Group | 88.35B |
| Akeso | 85.05B |
| Sichuan Kelun-Biotech Biopharmaceutical | 78.30B |